Company / SG&A Expense
Bruker SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$946.5M
FY2025
5-year range
$561.2M / $946.5M
FY2021-FY2025
Trend
+5.9%
vs FY2024
Sector context
#47 of 152
Health Care
What the data says
At $947M, Bruker's sg&a expense ranks #106 of 152 in the Health Care sector. SG&A Expense has increased for 5 consecutive years, from $469M in FY2020 to $947M in FY2025.
Based on SEC 10-K filings.
$947M in FY2025 with a 5-year CAGR of +15.1%.
Increased from $729M to $947M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +15.9%
- 5-Year CAGR
- +15.1%
- 10-Year CAGR
- -
Sector benchmark
#106 of 152 in Health CareTop 69% of 152This company $946.5M Sector average $182.7B
▼
-99.5% below sector average
Key checks
Key Insights
- Bruker's sg&a expense has grown for 5 consecutive years.
- 5-year CAGR of +15.1%, indicating consistent growth.
- In FY2025, sg&a expense increased 5.9% year-over-year.
- Ranks #47 out of 152 companies in the Health Care sector.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $946.5M | +5.9% |
| FY2024 | $893.8M | +22.5% |
| FY2023 | $729.4M | +20.1% |
| FY2022 | $607.4M | +8.2% |
| FY2021 | $561.2M | +19.8% |
| FY2020 | $468.6M | -6.3% |
| FY2019 | $500.2M | +12.5% |
| FY2018 | $444.7M | +7.1% |
| FY2017 | $415.2M | +6.5% |
| FY2016 | $389.8M | -0.6% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026